Nov 07, 2017 12:01 pm UTC| Business
WATERLOO, Ontario, Nov. 07, 2017 -- Client Outlook Inc., the developer of FDA Class II diagnostic and clinical imaging software platform, eUnity, announced today a new partnership with patient-driven healthcare...
Trevena Reports Third Quarter 2017 Financial Results and Announces New Positive Clinical Trial Data
Nov 07, 2017 12:01 pm UTC| Business
– New ATHENA data show OLINVO effectiveness with promising safety/tolerability in key target procedures – – Positive interim data for Phase 1 study of investigational migraine treatment TRV250 leads to study expansion – ...
Nov 07, 2017 12:01 pm UTC| Business
BERKELEY, Calif. and DENVER, Nov. 07, 2017 -- Lygos, a leading innovator in the development of sustainable high-value specialty chemicals, today announced a breakthrough in scaling Lygos’ proprietary process for making...
Nov 07, 2017 12:01 pm UTC| Business
RICHMOND, Va., Nov. 07, 2017 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the third quarter of 2017 of $54.6 million. This represents an increase of $20.3 million or 59% when compared to net...
Nov 07, 2017 12:01 pm UTC| Business
NEW YORK, Nov. 07, 2017 -- DropCar, Inc. (“DropCar”), a software and logistics provider of cloud- and app-based vehicle support and concierge services for both the automotive industry and consumers, today announced the...
Keryx Biopharmaceuticals Announces Third Quarter 2017 Financial Results
Nov 07, 2017 12:01 pm UTC| Business
Company reported $15.0 million in third quarter 2017 total revenues, including net U.S. Auryxia® product sales of $13.6 millionU.S. Food and Drug Administration (FDA) approves Auryxia® (ferric citrate) tablets as a...
Nov 07, 2017 12:01 pm UTC| Business
Auryxia is the only oral treatment option available today developed and approved specifically for adults living with iron deficiency anemia and chronic kidney disease, not on dialysisOne in seven adults in the U.S. is...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update